Evidence for active closure of patent ductus arteriosus in very preterm infants

Journal of Pediatrics

Volumn 152, Issue 3, 2008, Pages 446-447

  Knight, David B ^a   Laughon, Matthew M ^b  

^a AUCKLAND CITY HOSPITAL   (New Zealand)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INDOMETACIN; PLACEBO;

ARTIFICIAL VENTILATION; BRAIN HEMORRHAGE; CLINICAL TRIAL; ECHOCARDIOGRAPHY; HEART SURGERY; HUMAN; LETTER; LUNG HEMORRHAGE; MORBIDITY; OXYGEN THERAPY; PATENT DUCTUS ARTERIOSUS; PREMATURITY; PRIORITY JOURNAL; TREATMENT OUTCOME;

DUCTUS ARTERIOSUS, PATENT; FEMALE; HEMOTHORAX; HUMANS; INDOMETHACIN; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, VERY LOW BIRTH WEIGHT; MALE; META-ANALYSIS AS TOPIC; OXYGEN; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESPIRATION, ARTIFICIAL; RISK ASSESSMENT; SURVIVAL ANALYSIS; ULTRASONOGRAPHY, DOPPLER;

EID: 38949118968     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2007.10.016     Document Type: Letter

References (12)

1. Clyman R.I., and Chorne N. Patent ductus arteriosus: evidence for and against treatment. [editorial]. J Pediatr 150 (2007) 216-219
2. Fowlie P.W., and Davis P.G. Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants. Cochrane Database Syst Rev (2002) CD000174
3. Mahony L., Caldwell R.L., Girod D.A., Hurwitz R.A., Jansen R.D., Lemons J.A., et al. Indomethacin therapy on the first day of life in infants with very low birth weight. J Pediatr 106 (1985) 801-805
4. Mahony L., Carnero V., Brett C., Heymann M.A., and Clyman R.I. Prophylactic indomethacin therapy for patent ductus arteriosus in very-low-birth-weight infants. N Engl J Med 306 (1982) 506-510
5. Hammerman C., Strates E., and Valaitis S. The silent ductus: its precursors and its aftermath. Pediatr Cardiol 7 (1986) 121-127
6. Hammerman C., Strates E., Komar K., and Bui K. Failure of prophylactic indomethacin to improve the outcome of the very low birth weight infant. Dev Pharmacol Ther 10 (1987) 393-404
7. Kääpä P., Lanning P., and Koivisto M. Early closure of patent ductus arteriosus with indomethacin in preterm infants with idiopathic respiratory distress syndrome. Acta Paediatr Scand 72 (1983) 179-184
8. Yanagi R.M., Wilson A., Newfeld E.A., Aziz K.U., and Hunt C.E. Indomethacin treatment for symptomatic patent ductus arteriosus: a double-blind control study. Pediatrics 67 (1981) 647-652
9. Cotton R.B., Hickey D.E., Graham T.P., and Stahlman M.T. Effect of early indomethacin (I) on ventilatory status of preterm infants with symptomatic patent ductus arteriosus. Pediatr Res 14 (1980) 442
10. Cotton R.B., Stahlman M.T., Bender H.W., Graham T.P., Catterton W.Z., and Kovar I. Randomized trial of early closure of symptomatic patent ductus arteriosus in small preterm infants. J Pediatr 93 (1978) 647-651
11. Levitsky S., Fisher E., Vidyasagar D., Hastreiter A.R., Bennett E.J., Raju T.N.K., et al. Interruption of patent ductus arteriosus in premature infants with respiratory distress syndrome. Ann Thorac Surg 22 (1976) 131-137
12. Rojas M.A., Gonzalez A., Bancalari E., Claure N., Poole C., and Silva-Neto G. Changing trends in the epidemiology and pathogenesis of neonatal chronic lung disease. J Pediatr 126 (1995) 605-610